Filter trials by:

Year

Indication

Phase

Type

Year: 2007

A Randomized, Double-Blind, Placebo- Controlled, Multicentre Phase III Study to Evaluate the Long-Term Safety of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain.

Year: 2007
Type: Pharmaceutical - Pain
Phase: III
Indication: Pain - General

A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects.

Year: 2007
Type: Musculoskeletal
Phase: II
Indication: Fibromyalgia